Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| Hs 578T | Erlotinib | 3.1623 | uM | 10 | 156.25 | 66.59 | 279.00 | 297.00 | 0.9394 | 0.9429 |
| Hs 578T | Erlotinib | 1 | uM | 10 | 156.25 | 66.59 | 349.00 | 297.00 | 1.1751 | 1.1553 |
| Hs 578T | 0 | uM | 10 | 156.25 | 66.59 | 307.00 | 297.00 | 1.0337 | 1.0309 | |
| Hs 578T | 0 | uM | 10 | 156.25 | 66.59 | 336.00 | 297.00 | 1.1313 | 1.1177 | |
| Hs 578T | Linsitinib | 3.1623 | uM | 10 | 156.25 | 66.59 | 366.00 | 297.00 | 1.2323 | 1.2034 |
| Hs 578T | Linsitinib | 0.01 | uM | 10 | 156.25 | 66.59 | 388.00 | 297.00 | 1.3064 | 1.2638 |
| Hs 578T | Erlotinib | 19.9526 | uM | 10 | 156.25 | 66.59 | 324.00 | 297.00 | 1.0909 | 1.0823 |
| Hs 578T | 17-AAG | 0.0016596 | uM | 10 | 156.25 | 66.59 | 255.00 | 297.00 | 0.8586 | 0.8635 |
| Hs 578T | 17-AAG | 1 | uM | 10 | 156.25 | 66.59 | 64.00 | 297.00 | 0.2155 | -0.0182 |
| Hs 578T | Erlotinib | 0.1 | uM | 10 | 156.25 | 66.59 | 240.00 | 297.00 | 0.8081 | 0.8119 |
| Hs 578T | 17-AAG | 0.031623 | uM | 10 | 156.25 | 66.59 | 59.00 | 297.00 | 0.1987 | -0.0546 |
| Hs 578T | 0 | uM | 10 | 156.25 | 66.59 | 307.00 | 297.00 | 1.0337 | 1.0309 | |
| Hs 578T | Lapatinib | 3.1623 | uM | 10 | 156.25 | 66.59 | 411.00 | 297.00 | 1.3838 | 1.3251 |
| Hs 578T | 17-AAG | 0.01 | uM | 10 | 156.25 | 66.59 | 128.00 | 297.00 | 0.4310 | 0.3538 |
| Hs 578T | 0 | uM | 10 | 156.25 | 66.59 | 444.00 | 297.00 | 1.4949 | 1.4098 | |
| Hs 578T | Erlotinib | 10 | uM | 10 | 156.25 | 66.59 | 257.00 | 297.00 | 0.8653 | 0.8703 |
| Hs 578T | Erlotinib | 0.01 | uM | 10 | 156.25 | 66.59 | 371.00 | 297.00 | 1.2492 | 1.2173 |
| Hs 578T | Lapatinib | 10 | uM | 10 | 156.25 | 66.59 | 137.00 | 297.00 | 0.4613 | 0.3972 |
| Hs 578T | Linsitinib | 19.9526 | uM | 10 | 156.25 | 66.59 | 185.00 | 297.00 | 0.6229 | 0.6059 |
| Hs 578T | Erlotinib | 0.0033113 | uM | 10 | 156.25 | 66.59 | 303.00 | 297.00 | 1.0202 | 1.0186 |
| Hs 578T | Erlotinib | 0.031623 | uM | 10 | 156.25 | 66.59 | 450.00 | 297.00 | 1.5152 | 1.4249 |
| Hs 578T | Lapatinib | 1 | uM | 10 | 156.25 | 66.59 | 238.00 | 297.00 | 0.8014 | 0.8049 |
| Hs 578T | 17-AAG | 0.1 | uM | 10 | 156.25 | 66.59 | 64.00 | 297.00 | 0.2155 | -0.0182 |
| Hs 578T | Lapatinib | 0.01 | uM | 10 | 156.25 | 66.59 | 377.00 | 297.00 | 1.2694 | 1.2338 |
| Hs 578T | 0 | uM | 10 | 156.25 | 66.59 | 232.00 | 297.00 | 0.7811 | 0.7836 |